Drosophila models of PIGA-CDG mirror patient phenotypes
Holly J. ThorpeiD, Katie G OwingsiD, Miriam C. AziziD, Madelyn Haller, Emily Coelho, Clement Y. ChowiD
Abstract
Mutations in the phosphatidylinositol glycan biosynthesis class A (PIGA) gene cause a rare, X-linked recessive congenital disorder of glycosylation (CDG). PIGA-CDG is characterized by seizures, intellectual and developmental delay, and congenital malformations. The PIGA gene encodes an enzyme involved in the first step of GPI anchor biosynthesis. There are over 100 GPI anchored proteins that attach to the cell surface and are involved in cell signaling, immunity, and adhesion. Little is known about the pathophysiology of PIGA-CDG. Here we describe the first Drosophila model of PIGA-CDG and demonstrate that loss of PIG-A function in Drosophila accurately models the human disease. As expected, complete loss of PIG-A function is larval lethal. Heterozygous null animals appear healthy, but when challenged, have a seizure phenotype similar to what is observed in patients. To identify the cell-type specific contributions to disease, we generated neuron- and glia-specific knockdown of PIG-A. Neuron-specific knockdown resulted in reduced lifespan and a number of neurological phenotypes, but no seizure phenotype. Glia-knockdown also reduced lifespan and, notably, resulted in a very strong seizure phenotype. RNAseq analyses demonstrated that there are fundamentally different molecular processes that are disrupted when PIG-A function is eliminated in different cell types. In particular, loss of PIG-A in neurons resulted in upregulation of glycolysis, but loss of PIG-A in glia resulted in upregulation of protein translation machinery. Here we demonstrate that Drosophila is a good model of PIGA-CDG and provide new data resources for future study of PIGA-CDG and other GPI anchor disorders. Article SummaryPIGA-CDG is a rare genetic disorder. In order to study this rare disease, we generated and characterized several Drosophila models of PIGA-CDG. These models faithfully recapitulate different patient phenotypes, including movement disorder and seizures. Drosophila is a good model for PIGA-CDG and other GPI anchor disorders.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG
Miriam C. Aziz, Jennie Wilson, Clement Y. Chow·PLoS GeneticsPeer-reviewed·Aug 31, 2026
- Identification of CNTN2 as a genetic modifier of PIGA-CDG through pedigree analysis of a family with incomplete penetrance and functional testing in Drosophila
Holly J. Thorpe, Brent S. Pedersen, … Clement Y. Chow·bioRxiv·Aug 12, 2024
- Limb-clasping, cognitive deficit and increased vulnerability to kainic acid -induced seizures in neuronal GPI anchor deficiency mouse models
Lenin C. Kandasamy, Mina Tsukamoto, … Qi Zhang·Human Molecular GeneticsPeer-reviewed·Feb 15, 2021
- CNS Glycosylphosphatidylinositol Deficiency Results in Delayed White Matter Development, Ataxia, and Premature Death in a Novel Mouse Model
Marshall Lukacs, Lauren E. Blizzard, Rolf W. Stottmann·Human Molecular GeneticsPeer-reviewed·Mar 11, 2020
- A CRISPR-Cas9-engineered mouse model for GPI-anchor deficiency mirrors human phenotypes and exhibits hippocampal synaptic dysfunctions
Miguel Rodríguez de los Santos, Marion Rivalan, … Peter Michael Krawitz·Proceedings of the National Academy of SciencesPeer-reviewed·Jan 5, 2021
- Genetic Dissection of the role of Piga and Pgap2 in the embryonic mouse brain
Jennifer L. Watts, Jesus M. Leal, Rolf W. Stottmann·iSciencePeer-reviewed·Jun 1, 2026